Drugs / Restylane Volyme
last change Mar 2025 re-read 3 minutes ago

Restylane Volyme

Developed for
midface dysplasia

Trials 0

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Comparator or background therapy1 trial
— NCT07359079 Comparator Mar 2025 → Nov 2026 expected midface dysplasia Chongqing Jinsaixing Medical Technology Co., Ltd Active not recruiting No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Restylane Volyme ClinicalTrials.gov intervention name — accepted as the source's own label NCT07359079 ↗